Scientists search for clues in ALS Patients' blood and spinal fluid
NCT ID NCT07260981
Summary
This study aimed to better understand Amyotrophic Lateral Sclerosis (ALS) by measuring specific proteins in the blood and spinal fluid of patients. Researchers compared samples from 60 people with early-stage ALS to samples from healthy individuals. The goal was to find biological clues that could help identify patient subgroups, track disease progression, and guide future treatment development.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALS (AMYOTROPHIC LATERAL SCLEROSIS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pioneer Life Sciences Cherrywood
Dublin, Ireland
Conditions
Explore the condition pages connected to this study.